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Spinal cord injury (SCI) results in motor and sensory deﬁcits, the severity of which depends on the level and extent of the injury.
Animal models for SCI research include transection, contusion, and compression mouse models. In this paper we will discuss
the endogenous stem cell response to SCI in animal models. All SCI animal models experience a similar peak of cell proliferation
three days after injury; however, each speciﬁc type of injury promotes a speciﬁc and distinct stem cell response. For example, the
transection model results in a strong and localized initial increase of proliferation, while in contusion and compression models,
the initial level of proliferation is lower but encompasses the entire rostrocaudal extent of the spinal cord. All injury types result
in an increased ependymal proliferation, but only in contusion and compression models is there a signiﬁcant level of proliferation
in the lateral regions of the spinal cord. Finally, the fate of newly generated cells varies from a mainly oligodendrocyte fate in
contusion and compression to a mostly astrocyte fate in the transection model. Here we will discuss the potential of endogenous
stem/progenitor cell manipulation as a therapeutic tool to treat SCI.
1.Introduction
In contrast to the former dogma that states that the adult
mammalian central nervous system (CNS) is a tissue incap-
able of cell proliferation [1, 2], neuroscientists currently
acknowledge the phenomena of postnatal mitosis in intact
and injured CNS tissue, including in the spinal cord [1–10].
Research directed to modify the rate of proliferation and
the fate of the newly generated cells in the spinal cord may
have the capacity to restore function after injury. Researchers
have followed diﬀerent experimental strategies to modulate
proliferation and cell diﬀerentiation in the spinal cord,
including the manipulation of the levels of growth factors
[11–18],proteinsintheglialscar[19,20],inﬂammation[21–
23], and factors known to impair regeneration [24, 25]. Here
we will discuss the response of endogenous stem/progenitor
cellsandthepotentialofmanipulatingthesestem/progenitor
cells as a therapeutic tool to treat spinal cord injury (SCI).
2. Spinal Cord Injury
Anestimated 265,000 people in theUnited Statessuﬀersome
form of SCI [26]. Patients with SCI have a reduced life
expectancy and experience a variable degree of impairment
of movement, sensation and urinary and bowel function.
Commonhealthcomplicationsarepneumonia,urinary tract
infections, and septicemia, all of which may result in recur-
rent hospitalizations. The degree of physical impairment,
costs associated with care, and life expectancy are directly
related to the level and extent of injury [27]. Lifetime costs
for a single patient with SCI in the USA are between 1.1
and 4.3 millions of dollars [26]. Higher level and/or more2 Stem Cells International
complete injuries generally have a poorer prognosis and
higher costs of care,whileindividuals withlower leveland/or
incomplete injuries typically have better clinical outcomes.
SCI consists of a primary injury that leads to a sec-
ondary injury cascade. The primary injury is a physical
insult, commonly induced by a compressive force of the
vertebrae on the spinal cord [21]. This mechanical injury
severs axons, causes necrotic cell death, and disrupts the
vasculature. Consequently, primary injury leads to edema
and ischemia, thus triggering a secondary injury cascade that
consists of inﬂammation and the release of free radicals and
cytotoxic levels of excitatory amino acids. This secondary
injury cascade causes a further damage to axons and
contributes to the death of numerous cell types [21, 39–
41]. The terms primary and secondary injury should not be
confused with acute and chronic SCI, which refers to the
amount of time that has passed since the primary injury.
Acute SCI is the ﬁrst two weeks after injury, when secondary
injury mechanisms are predominant and therapies for SCI
are most eﬀective, while the term chronic SCI refers to
periodsoftimegreaterthansixmonthsafterinjury[21].The
majority of cell proliferation occurs during the acute phase
of SCI [39]; thus this paper will focus on cell proliferation
during the acute phase of SCI.
Studies on cell response to SCI in humans are very lim-
ited due to issues of patient consent, technological constra-
ints, medical urgency, and tissue availability. Consequently,
animalmodelsforSCIformthebasisformuchofourcurrent
knowledge on how cells in the spinal cord are aﬀected by
injury. The most common clinical presentation of SCI in
human patients is a fracture dislocation injury in which the
vertebrae are compressed against the spinal cord. The con-
tusion model of animal SCI mimics this injury by applying
a force onto the dorsal aspect of the spinal cord. By using
this model on laboratory rodents, we can gain a better
understanding of the precise events that take place in the
spinal cord after injury and how regenerative therapies may
modulate cellular responses to injury.
Spinalcordinjurycausesrapidlossofallcelltypeswithin
the spinal cord. In a model of incomplete contusion (10g
weight from a height of 2.5cm), the rat spinal cord lost
approximately 66% of the ventral motor neurons at the
injury epicenter within 15 minutes of injury, and there was a
near complete loss within four hours [42]. Oligodendrocytes
expressing the marker antiadenomatosis polyposis coli clone
CC-1 (CC1) and astrocytes expressing the marker glial ﬁbril-
lary acidic protein (GFAP) also decreased within 15 minutes
to60%and90%ofuninjuredspinalcord,respectively.While
oligodendrocyte numbers did not recover during the acute
injury phase, the number of astrocytes rebounded within 24
hours. Adjacent tissues also demonstrated the loss of glial
and neuronal cells within 15 minutes of injury. Loss of all cell
types is a prominent feature of SCI and occurs in all injury
models, despite to varying degrees depending on injury type
and severity [17, 21, 33, 35, 43, 44]. Stem/progenitor cells
are also susceptible to injury. Horky et al. administered
the proliferative marker bromodeoxyuridine (BrdU) prior to
injury to label endogenous proliferating cells in the spinal
cord. The number of BrdU+ cells labeled decreased by 67%
within one day of a hemisection injury in mouse [30].
Approximately half of those proliferative cells expressed
neuron-glial antigen 2 (Ng2), a marker of oligodendrocyte
progenitor cells (OPCs). McTigue et al. also reported that
approximately half of the endogenous OPCs were lost in
the rat spinal cord after contusion injury, as well as a large
numberofoligodendrocyteswithintheinjuryepicenter[33],
a result corroborated in a mouse model of contusion injury
[17]. The loss of OPCs and oligodendrocytes may account
for the delay in recovery of mature oligodendrocytes after
injury. Axonal demyelination peaks during the ﬁrst week,
and is followed by remyelination that begins within 14 days
of injury concomitantly with a recovery in the number of
mature oligodendrocytes [33]. After injury, there is a tissue
shrinkage in areas caudal to the lesion with more severe
injuries resulting in a greater reduction in the spinal cord
volume [1, 36]. To mimic SCI in human, researchers use a
variety of animal models and injury types.
3. Models of SpinalCord Injury
ValuableanimalresearchmodelsforSCIshoulddemonstrate
reproducible deﬁcits in locomotor and sensory behaviors.
Furthermore, SCI animal models should be adjustable to
produce injuries of diﬀering severity, which must correlate
with the degree of neurological deﬁcit observed. There are
many forms of SCI, both clinically observed and experimen-
tally validated, that can be classiﬁed into three groups of
models based on the type of injury: transection, contusion,
and compression.
Transection SCI models are all forms of laceration to
the spinal cord. Some common transection models include
complete transection, in which a blade is passed through
the entirety of the dura mater and spinal cord, dorsal or
lateral hemisection, in which a blade is passed only half-
way through the spinal cord (Figure 1(a)), and incision or
minimalinjurymodels,inwhichsmallnicksorcutsaremade
through the dura into the spinal cord. The pathological fea-
tures of transection include a complete severance of axons in
the area transected and the formation of a connective tissue
mass and glial scar comprised of meningeal ﬁbroblasts and
astrocytes. Lacerations are rarely seen clinically, but may be
present in instances of knife or gunshot wounds. Transection
injuries are an attractive SCI model in experimental studies
which aim to direct axonal growth through the glial scar
[45].
Contusion injuries are produced by a focal force acting
on the spinal cord, most commonly from the dorsal aspect
[45]. Features of this experimental model include an intact
glial limitans and pia mater and the formation of cavities
within the spinal cord, a secondary complication known as
syringomyelia in humans. Contusion injuries are character-
ized by a rim of spared white matter and cytoarchitectonic
disorganization (Figure 1(b))[ 1]. Experimentally, contusion
injuries are performed using a weight drop method or
dedicated apparatus such as the NYU or OSU impactor [46].
In contusion models, the severity of injury is controlled by
increasing the weight or height from which the impactor tip
is dropped.Stem Cells International 3
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Figure 1: Qualitative summary of the features of the three types of animal models of SCI. Diagrams were created based on the references
listedinTable 1.(a)Examplesoftransectioninjuriesincludedorsalhemisections(left),lateralhemisections(right),andcompletetransection
(bottom). Proliferation peaks at 3dpi and tapers oﬀ by 9dpi. The mitotic response to injury is localized to the epicenter. Transection injuries
are characterized by daughter cells acquiring astrocyte and macrophage/microglia fates. These cell types migrate to the region of injury.
Depicted in the two right-most diagrams is proliferation and cell fate preferences in a dorsal hemisection injury. (b) A contusion injury
typically results in a rim of spared white tissue. In response to injury, proliferation peaks at 3dpi and is elevated for 14 days. Contusion
injuries are characterized by a proliferative response that spans the rostrocaudal extent of the spinal cord. Cell fate of mitotic cells trends
towards the oligodendrocyte lineage, but astrocytes and microglia also represent a portion of dividing cells. (c) Compression injuries closely
resemble contusion injuries both in the extent of the spinal cord aﬀected and cell types generated.
Compression injuries closely resemble contusion injuries
in terms of pathological properties and neurological impair-
ment; however, they diﬀer in several regards. Contusion
injuries are focal dorsal compressions, while in compression
models the force can be applied either laterally or dorsally
depending on the apparatus used. A compression injury can
be generated using the Plemel method of calibrated forceps
compression [47], aneurysm clips [45], or by applying a
known weight directly onto the spinal cord [38]. The injury
produced by compression generally aﬀects a broader rostro-
caudalareathancontusionanddependingontheapplication
of force, may aﬀect the lateral spinal cord more than the
dorsal. Depending on the degree of severity, a compression
injury may closely resemble a contusion injury in terms
of pathology and cytoarchitectural distortions (Figure 1(c))
[47]. Injury severity is increased by compressing the spinal
cord to a smaller diameter, by choosing aneurysm clips
capable of applying greater pressure, or by increasing the
amount of time the apparatus compresses the spinal cord.
Depending on the method used and injury severity, the glial
limitans or pia may be lacerated [45].
4. Proliferation in the Intact SpinalCord
Neural stem cells (NSCs) are inherently diﬃcult to identify
and study. This is due in a large part to their heterogeneity
of morphology and marker expression, as well as the lack of
an identiﬁed anatomical niche [48–52]. The heterogeneity of
marker expression in NSCs results in a signiﬁcant overlap in
markerexpressionbetweenNSCsandmatureastrocytes[48–
57], which further complicates eﬀorts to identify which cell
types are NSCs and where they reside within the spinal cord.
To be classiﬁed as a stem cell, a CNS cell should be able to
self-renew and to give rise to all types of mature neural cells
includingneurons,astrocytes,andoligodendrocytes[2,8,28,
58,59].Totestneural“stemness”researchersisolatepotential
stem cells and plate them in culture to form neurospheres
that are further passaged to generate secondary neuro-
spheres. Proliferative cells are considered neuronal stem cells
if they form primary and secondary neurospheres and if cells
diﬀerentiate into neurons, astrocytes, and oligodendrocytes
in vitro [2, 8, 58, 60]. Fate restricted precursor cells capable
of self-renewal, but limited to what fates their daughter cells4 Stem Cells International
can acquire, are not considered stem cells and are referred
as progenitor cells [4, 60]. An example of progenitor cells in
the spinal cord are OPCs, which are capable of self-renewal
and produce oligodendrocytes. Intriguingly, neurospheres
derived from the spinal cord exhibit multipotency in vitro
andarecapableofbecomingneuronswhentransplantedinto
thehippocampus,butwhentransplantedintothespinalcord
t h e yo n l ya c q u i r eg l i a lf a t e s[ 60]. Thus, some cells in the
spinal cord are multipotent under certain conditions, but the
native environment of the spinal cord is not conducive to
fully realizing this potential. This disparity between in vitro
capability and in vivo behavior raises the question of whether
or not spinal cord cells capable of forming neurospheres
in vitro are truly multipotent stem cells. In this paper we
will discuss experiments used to identify populations of cells
within speciﬁc regions of the spinal cord with capacity to
self-renew and generate daughter cells that express markers
of mature CNS cells.
Although early studies showed postnatal neurogenesis in
the brain [61–63], studies by Weiss et al. [2], Kehl et al.
[7], Shihabuddin et al. [58], and Johansson et al. [8]w e r e
among the ﬁrst to isolate and characterize stem/progenitor
cells in the adult mammalian spinal cord. Weiss et al. isolated
cells from the adult mouse spinal cord and, by culturing
cellswithepidermalgrowthfactor(EGF)andbasicﬁbroblast
growth factor (FGF2), generated neurospheres capable of
diﬀerentiating into all three major CNS cell types: neurons,
oligodendrocytes, and astrocytes [2]. Shihabuddin et al.
achieved similar results on tissue isolated from adult rat
spinal cord, although they determined that FGF2 alone was
suﬃcient for the isolation and culture of spinal cord
stem/progenitor cells [58]. Similarly, Kehl et al. isolated and
characterized stem/progenitor cells from the entire postnatal
rat cervical spinal cord, but cultured these cells under
monolayer conditions [7]. Under such conditions, cells
were capable of mitosis and diﬀerentiation into functional
neurons. These early reports were signiﬁcant in that they
described the presence of multipotent progenitors in the
adult spinal cord. Neither of these studies described where
the cells were located within the spinal cord, their lineage, or
what markers they expressed in vivo. Later studies by Johans-
son et al. [8] and Yamamoto et al. [28] provided evidence
of stem/progenitor cell presence within the central canal and
lateral parenchyma of the spinal cord, respectively.
Theependymallayerofthespinalcordhasreceivedmuch
attention due to its role during embryonic development as
a neuroprogenitor cell niche, its relation to the ependymal
and subependymal layers of the brain, and its role in the
reconnection and regeneration of the spinal cord of lower
vertebrates. The central canal of the postnatal vertebrate
spinal cord is congruent with the ventricular system of the
brain and is similarly lined with a pseudostratiﬁed layer of
ependymal cells [8, 64, 65]. However, unlike in the brain,
there is no underlying subventricular zone (SVZ) in the
spinal cord. Ependymal cells are ciliated cells with the soma
located at the ventricular surface and a basal process in
contact with the pia [66]. During development, proliferation
occurs at the ventricular surface of the spinal cord, followed
by subsequent migration of the daughter cells away from
the central canal and their diﬀerentiation [4, 67]. In non-
mammalian vertebrates, the ependymal cells in the postnatal
spinal cord retain proliferative and neurogenic properties
in both normal and injured spinal cord [66, 68, 69]. How-
ever, in mammals, the proliferative properties of postnatal
ependymal cells in the spinal cord are more restricted and
the frequency of proliferation is lower [3, 8, 59, 65, 70].
Ependymal cells in the mammalian spinal cord express
markers associated with neural stem cells such as Nestin,
GFAP, brain lipid binding protein (BLBP), Sox2, Vimentin,
Musashi1, alpha-type platelet derived growth factor
(PDGFR-α), Sox3, FoxJ1, and Notch1 receptor [8, 32, 52].
However, ependymal cells are highly heterogeneous in
their marker expression, making the characterization of
e p e n d y m a lc e l ls u b t y p e sd i ﬃcult. Several studies on the
turtle spinal cord utilizing transmission electron microscopy
(TEM), immunohistochemistry, and electrophysiology have
characterized many subtypes of ependymal cells and
surrounding cells in contact with the central canal [71–73].
Molecular evidence indicates that some ependymal cells in
the postnatal spinal cord express the neuronal markers dou-
blecortin, HuC/D, and/or polysialylated-neural cell adhesion
molecule(PSA-NCAM).Justasthemarkerexpressionproﬁle
of ependymal cells is variable, so are their morphologies.
Ependymal cells in the dorsal and ventral poles of the central
canal resemble radial glial cells in the brain with long basal
processes in contact with the pia mater and a short apical
process in contact with the ventricular surface [65, 74],
while the remainder of ependymal cells have cuboidal or
tanycyte morphologies [65, 71]. Ependymal cells in turtle
closely match the marker expression proﬁle and morphology
in mammals, indicating that some properties of ependymal
cells are evolutionarily conserved among vertebrates despite
the diﬀerential regenerative capabilities of these organisms
in response to SCI. Understanding the precise diﬀerences
between nonmammalian and mammalian spinal cord may
enable therapies for SCI in humans to be capable of evoking
the same level of plasticity observed in lower vertebrates.
Recent studies also identiﬁed stem/progenitor cell prolif-
eration in regions of the spinal cord away from the central
canal. Horner et al. described proliferation in regions of the
lateral parenchyma in intact adult rat spinal cord [4]. By
using a single pulse of BrdU and collecting the spinal cord
one hour later, they discovered that most of the BrdU+ cells
were located in the outer circumference of the spinal cord,
and concluded that these cells could not have originated
from the ependymal cells of the central canal. These BrdU+
cellswere predominately Ng2+, but also coexpressed markers
for astrocytes, such as S100 calcium binding protein b
(S100b), and for oligodendrocytes, such as antioligoden-
drocyte marker clone NS-1 (RIP), but did not express the
neuronal markers class III β-tubulin (Tuj1) or neuronal
nuclei (NeuN). A similar study by the Fris´ en Laboratory,
using transgenic mice with an inducible Cre-LoxP system for
lineage tracing, found that only ependymal cells were able
to generate neurospheres. Proliferating cells of the Olig2+
lineage in the parenchyma did not but self-renewed and
generated mature oligodendrocytes, ascribing to them a
role as OPCs [3]. On the other hand, work by YamamotoStem Cells International 5
et al. on rat spinal cord supported a stem/progenitor cell
niche along the outer circumference of the adult spinal
cord based on the ability of dissociated and cultured lateral
parenchyma to form neurospheres [28]. The Yamamoto
study suggested that there is only one cell population in
the lateral parenchyma capable of neurosphere formation
and multipotent diﬀerentiation into the three main CNS
cell types, but provided no evidence to where exactly in the
parenchyma this cell population may be located nor what
t h i sc e l lp o p u l a t i o nm a yb ei nt e r m so fc e l ll i n e a g eo rm a r k e r
expression.TheFris´ enstudyruledoutOlig2+ cellsasacandi-
date cell population to fulﬁll the role of stem/progenitor cells
observed in the lateral parenchyma by Yamamoto et al. and
Horner et al. The existence of a stem/progenitor cell niche
in the lateral parenchyma is further supported by a recent
study by Petit et al. that proposed, based on morphology and
marker expression, that some nonependymal proliferating
cells located in the subpial white matter of the mouse spinal
cord are putative adult radial glia (RG) [52]. These cells
expressed a combination of neonatal RG markers such as
BLBP, Reelin, glutate aspartamate transporter (GLAST), and
the adult neural stem cell markers GFAP and Sox2. During
embryonic development the transient expression of BLBP
parallels neurogenesis, and there is evidence from transgenic
mouse studies that nearly all neurons in the mouse brain
are derived from BLBP+ RG [53]. Additionally, BLBP+ cells
with RG morphology are localized to the central gelatinosa
surrounding the central canal in the adult turtle [72, 75], are
implicated in the reconnection of the turtle spinal cord after
transection [68, 76] and are directly involved in the regener-
ation of the axolotl spinal cord after amputation of the tail
[77]. In mammalian models of injury, BLBP+ cells do not
reconnectthespinalcordbutundergomitosisatanincreased
rate after injury [52]. Confounding the identiﬁcation of stem
cells in the CNS is the overlap in marker expression between
neural stem cells and astrocytes, especially with regards to
BLBP and GFAP. Neural stem cells in the adult brain are
astroglial cells derived from RG cells that may fulﬁll the same
role in the adult brain as RG cells in the developing brain
[50, 51, 54–57, 78–82]. Taking this data into context, the
BLBP+ cells of Petit et al. may be analogous to RG-derived
astroglia in the adult brain. However, due to similarities
in marker expression, morphology, and response to injury,
further study is needed to diﬀerentiate this cell population
from functional astrocytes. BLBP+ cells from the subpial
whitematterofthespinalcordcouldbeisolatedandcultured
under conditions conducive to neurosphere formation to
determine if they represent a pool of multipotent cells in the
lateral parenchyma of the adult spinal cord.
As the predominant dividing cell type in the intact
postnatal spinal cord [4], Ng2 expressing cells have received
a great deal of scientiﬁc interest. Ng2+ c e l l sa r ec a p a b l eo f
forming self-renewing neurospheres in vitro that are only
able to produce oligodendrocytes [83], express a heteroge-
neous assortment of cell markers, and respond to injury
with increased mitosis [35, 36, 84, 85]. Cells expressing
Ng2 are found throughout the grey and white matter of
the intact rodent spinal cord [4, 86], although bipolar or
unipolar Ng2+ c e l l si nt h ew h i t em a t t e ra r ep r e f e r e n t i a l l y
associated with radial elementsof thespinal cord[4]. During
development, Ng2+ cells are closely associated with RG cells
[87]; thus the association of Ng2+ cells with radial elements
in the spinal cord and the aﬃliation of putative adult RG
cells described by Petit et al. with these same elements [52]
is similar to the relationship between RG and Ng2+ cells
during development. Ng2+ cells are generally considered
to be OPCs; however, there is a large body of evidence
suggesting that there are two distinct Ng2+ cell populations
and that only one of them functions as an OPC [17, 18,
83, 85, 86, 88, 89]. These two types of Ng2+ cells diﬀer in
morphology; one class of Ng2+ c e l l si ss t e l l a t es h a p e dw i t h
highly branched processes, while the other class of Ng2+ cells
has a ﬂat, epithelioid soma and fewer processes [83, 86, 89].
These subsets of Ng2+ cells diﬀer in their response to injury
and growth factor treatment, electrophysiology, and in their
potential for acquiring speciﬁc cell fates [17].
Of further note is the distribution of stem/progenitor
cells throughout the spinal cord along the rostral-caudal
axis. Horner et al. found more BrdU+ cells within the outer
circumference in the cervical and lumbar spinal cord than
in the thoracic spinal cord [4], while Petit et al. found an
increasing number of BLBP+ putative RG cells at the pial
edge in a cervical to lumbar gradient [52]. Similarly, Weiss
et al. found that a greater number of neurospheres were gen-
erated from lumbar and sacral spinal cord than from rostral
levels of spinal cord [2], but it is diﬃcult to compare these
studies because of the diﬀerent experimental methods used.
Olig2+ cells can be accounted for by BrdU labeling in the
Horner study, which labeled all mitotic cells, but Olig2+ cells
did not give rise to neurospheres and would not be repre-
sented in the Weiss study. If the cells described by Petit et al.
are true stem cells capable of neurosphere formation, their
population gradient might explain the increased numbers of
neurospheres generated from lumbar spinal cord by Weiss et
al. Using neurosphere formation as a criteria for deﬁning a
pool of stem/progenitor cells, these studies provide evidence
that there is a cervical to lumbar gradient of stem/progenitor
cells, and that speciﬁc levels of the spinal cord may have the
capacity to generate a more robust and eﬃcient response to
injury.
5. Proliferation after Injury
Lower vertebrates, such as eel [69], axolotl [77, 90], and
zebraﬁsh [91], are capable of replacing motor neurons and
making a complete functional recovery after SCI. Turtles
are capable of a signiﬁcant, albeit incomplete, recovery of
motor function [68]. However, there is little evidence for
neurogenesis in mammals after injury and spontaneous
functional improvement is modest at best. Despite the
diﬀerent functional outcomes, both nonmammalian and
mammalian spinal cords initiate a mitotic response to injury.
The mouse spinal cord is capable of forming neurospheres
in vitro [2, 8]; however, when the lateral parenchyma from
the injured spinal cord was cultured, neurospheres formed at
a greater frequency grew faster and were more robust than
neurospheres cultured from intact spinal cord tissue [3, 28].
Furthermore, when mice were administered BrdU prior to6 Stem Cells International
transection injury and the spinal cord tissue was dissociated
and cultured, most of the neurospheres originated from
BrdU+ cells had proliferated in response to injury [28].
Neurospheres derived under these conditions were capable
of generating neurons in vitro, indicating that some cells that
proliferate in response to SCI are multipotent under speciﬁc
conditions; however, the lack of neurogenesis after injury in
vivo indicates that the postnatal spinal cord environment is
not conducive to the generation of new neurons.
5.1. Proliferation in Transection Models. Proliferation at the
central canal plays an important role in the reconnection of
the transected spinal cord of lower vertebrates such as the
eel [69], turtle [68, 76], and lizard [92]. In the eel, the cross-
sectional area of the central canal increased two- to eight-
fold after a transection injury. The central canal reformed
and grew into a regenerating gap, then expanded dorsally,
re-creating the dorsal horns, which met and fused within 20
days of injury. Concomitant with the formation of a bridge
and dorsal expansion, ependymal proliferation increased
during the ﬁrst 20 days and then decreased after the fusion of
the regenerated dorsal horns. Ultimately, within 30 days the
eel was capable of the swimming behavior indistinguishable
from uninjured eels [69]. In the turtle, immediately after
injury a connective bridge, consisting of GFAP+ and BLBP+
cells, was formed between the resected ends of the spinal
cord [68]. By the end of the second week after injury, axons
invaded the cellular bridge and within two to three months
functional recovery was signiﬁcant but incomplete, with
permanent deﬁcits in stepping and coordination.
In contrast to the signiﬁcant functional recovery in lower
vertebrates, the spinal cord of higher order vertebrates such
as rat and mouse has a far more limited potential for
spontaneous recovery of motor and sensory function after
injury. However, like lower vertebrates, mammals experience
cell proliferation and there is evidence of repair mechanisms
in the form of the remyelination of damaged axons. One of
the earliest studies to characterize mammalian ependymal
cells as putative progenitor cells examined the ependymal
response to incision injury in rats. The in vivo proliferation
rate of spinal cord ependymal cells was very low, but
after an incision in the dorsal funiculus, the proliferation
of the ependymal layer increased 50-fold [8]. Ependymal
cells labeled with the ﬂuorescent dye Dil proliferated and
migrated over four weeks towards the lesion site, where they
contributed to glial scar formation and expressed GFAP.
Similarly, after a mild transection injury in rat, performed
with a 30-gauge needle to create a minimal lesion adjacent
to the central canal [29], ependymal proliferation increased
one day after injury and peaked three days after injury, at
which time point Dil+ cells were present within 70μmo f
the central canal [29]. Migration of labeled ependymal cells
continued up to 140μm from the central canal towards the
lesion at later time points. Additional experiments on the
proliferative response to a more severe transection injury
by Horky et al. described a signiﬁcant increase in BrdU+
cells after a dorsal hemisection injury in mouse [30]. These
cells were localized to the dorsal columns, neighboring grey
matter at the lesion epicenter, and at the central canal. The
greatest rate of proliferation occurred between three and
nine days after injury. BrdU+ cells of the ependymal layer
expressed either S100b or Nestin at early time points, which
diminished over time. Within the spinal cord parenchyma,
BrdU+/Ng2+ cells were abundant at all time points, while
mature oligodendrocytes expressing CC1 were present one
week after injury.
As already discussed, Yamamoto et al. was able to gener-
ate neurospheres from the lateral parenchyma of both intact
and injured rat spinal cord [28]. In a follow-up study, they
characterized the expression of neurogenic transcription
factors after a transection injury. Only after injury did some
ependymal cells express Pax6, although this expression was
transient and limited to the ﬁrst week after injury. Some cells
in the lateral parenchyma also transiently expressed Pax6,
andcellsinthedorsalhornbrieﬂyexpressedPax7.Onlysome
of these Pax6+ or Pax7+ cells coexpressed BrdU. Due to the
timing of their emergence and distance from the ependymal
layer, the authors concluded that Pax6+ cells in the lateral
parenchyma could not have migrated from the central canal.
It is possible that these cells were upregulating Pax6 in
response to injury and/or becoming mitotic and producing
daughter cells that expressed Pax6. Expression of Nkx2.2
increased throughout the medial and lateral parenchyma in
a temporal pattern similar to that observed in the Pax6+ and
Pax7+ cell populations. Pax6, Pax7, and Nkx2.2 are master
regulators that confer a regional identity on neuroprogenitor
cells during the embryonic development, with Pax6+ cells
giving rise to ventral motoneurons and oligodendrocytes
[93–97], Pax7+ cells giving rise to dorsal interneurons
[95, 98, 99], and Nkx2.2+ cells giving rise to primarily
oligodendrocytes [100]a n das u b s e to fv e n t r a ln e u r o n s[ 95].
Additionally, Pax6 is expressed in the adult SVZ by RG cells
[78–82]. Pax6 and Pax7 are not expressed in postnatal mam-
malian spinal cord tissue; however, they are in cells located
in the adult spinal cord of lower vertebrates. These cells
represent a neurogenic niche capable of responding to injury
by undergoing mitosis and generating a variety of cell fates
that contribute to functional recovery [72, 73, 77, 90, 91].
T h e s er e g u l a t o r so fc e l lf a t ed e t e r m i n a t i o na c t i v a t ed o w n -
streamneurogenictranscriptionfactorssuchasNeurogenin2
(Ngn2), Mash1, Hb9, Isl-1/-2, Lbx3, and NeuroD1 [95, 98,
99]. While Yamamoto et al. observed the expression of some
of these downstream transcription factors in vitro in a reca-
pitulation of embryonic development, they did not observe
similar gene expression in vivo after a transection injury
[59]. Neurospheres cultured in the presence of an antagonist
of Notch1, which is an inhibitor of Ngn2 and Mash1 and
a negative regulator of neurogenesis, gave rise to more
Tuj1+ cells than neurospheres cultured without a Notch1
inhibitor. This study raises the hypothesis that Notch1 is a
potential factor that contributes to limiting neurogenesis in
the postnatal spinal cord and identiﬁes Notch1 as a poten-
tial therapeutic target for regenerative therapies targeting
endogenous stem/progenitor cells in the spinal cord.
Studies from the Fris´ en Laboratory have attempted to
address the debate of which cell population(s) function as
neuralstemcellsinvivoafterinjury.TheyperformedadorsalStem Cells International 7
funiculus injury in transgenic mice in which Foxj1+ ependy-
mal cells, Cx30+ astrocytes, or Olig2+ oligodendrocytes
were labeled for cell fate mapping purposes. Ependymal
lineage cells increased four- to ﬁve-fold at the injury site
compared to adjacent regions, while cells of the glial
lineages increased twofold in response to injury [3, 32].
Cell proliferation occurred during the ﬁrst two weeks after
injury and remained at the same level after four months.
Cell migration also occurred after injury, with the cells
of the astrocyte lineage forming the periphery of the scar
and ependymal lineage cells composing the core of the
scar tissue. There was little diﬀerence in the number of
transgenically labeled cell populations between segments
adjacent to the injury site and control tissue, indicating
that the astrocytic and ependymal reaction to injury is
restricted to the lesion epicenter [3, 32]. Similar to their
results in intact spinal cord, the authors found that only
cells of the ependymal lineage had the potential to give
rise to diﬀerent cell types. An interesting observation is
that ependymal proliferation also occurred in response to
a lateral incision of the spinal cord, indicating that the
severance of the ependymal cell processes in the midline is
not necessary for activation; however it may augment the
ependymal proliferative response to injury [32]. This may
explain why other reports indicate that there is ependymal
proliferation, but at lower levels than reported in transection
models of injury [8, 29].
Proliferation after injury has also been observed in
nonhuman primates (macaque) with varying degrees of
transection injuries. Yang et al. described how a more severe
injury correlated with increased numbers of BrdU+ cells
both within the cervical lesion as well as in unlesioned
lumbar segments of the spinal cord [31]. In the macaque
spinal cord, 81% of BrdU+ cells in the lesion were Iba1+
microglia seven weeks after injury. These Iba1+ cells could
derive from peripheral macrophages that inﬁltrated the
damaged spinal cord tissue and proliferated. The issue of
nonnative cell proliferation accounting for BrdU+ cells has
been raised by other researchers and addressed by Horky et
al., who performed a hemisection injury on bone marrow
chimeric mice. They traced the migration of GFP-labeled
bone marrow stromal cells into the spinal cord after injury
and determined that less than 10% of BrdU+ cells originated
from proliferating peripheral blood cells [30]. It is thus
unlikely that a signiﬁcant portion of the BrdU+/Iba1+ cells
observed in the primate spinal cord after transection injury
derived from cell inﬁltrates and instead may be the result of
endogenous proliferating microglia or macrophages. Some
proliferative cells in the macaque spinal cord also expressed
Olig2,althoughthisproportiondeclinedovertimeasmature
oligodendrocyte and astrocyte markers increased [31]. There
w a sn oe v i d e n c eo fn e u r o n a ld i ﬀerentiation after injury in
theprimatespinalcord.Thesereportsdiﬀerfromtransection
studies on rats and mice in that injury to the primate spinal
cord evoked a proliferative response in distal regions of the
spinal cord and generated a larger proportion of BrdU+
microglial cells, features similar to reported results in animal
models of contusive and compressive SCI.
Sellers et al. focused on the response of Ng2+ cells to
injury. Their experiments demonstrated changes in the post-
injury extracellular environment of the spinal cord after
hemisection injury and the eﬀect that these cues had on
Ng2+. To label proliferating Ng2+ cells, which are likely to be
OPCs, they used an Ng2 promoter-speciﬁc retrovirus [18].
This retrovirus labels only proliferating cells and therefore
is used for birth dating studies. After injury, labeled cells
expressed markers for GFAP+ astrocytes, Iba1+ microglia,
andpericytes.Thisstudyproducedseveralinterestingresults,
such as the generation of S100b+ phagocytic astrocytes from
Ng2+ cells, which appeared within 24 hours at the lesion
epicenter and appeared to be engaged in clearing myelin
debris. However, a signiﬁcant ﬁnding was that Ng2+ cells
generated at diﬀerent time points after injury acquired dif-
ferent cell fates. Cells labeled with retrovirus on the ﬁrst day
after injury acquired an astrocyte fate by the third day, while
cells labeled on the seventh day became oligodendrocytes
expressing myelin basic protein (MBP). These changes in cell
fate determination were closely linked to changes in growth
factor expression within the spinal cord after injury.
Despite diﬀerencesin experimental methods, transection
injury in rat or mouse spinal cord evoked a localized prolife-
rative response, primarily of the ependymal cells; but some
Ng2+ OPCs and Ng2+ non-OPCs in the parenchyma also
entered a mitotic program. Although stem/progenitor cells
generate a variety of cell types, the majority of newly
born daughter cells acquired astrocytic fates (Figure 1(a)).
Ependymal cells are capable of migrating to the location
of injury and giving rise to multiple lineages. Proliferation
reached a peak at three days after injury and continued to be
elevated for one to two weeks, although the duration of the
proliferative response to transection injury is slightly unclear
due to variations in experimental methods between reports.
5.2. Proliferation in Contusion Models. Early studies of con-
tusion injuries in rabbit revealed an increased mitotic index
in the ependymal layer associated with an increase in the
diameter of the central canal at the lesion epicenter [9, 10].
A later study on contusion injury in rat, which examined
the relationship between injury severity and the amount of
ﬁber ingrowth, also described an expansion of the central
canal and an increase in ependymal cell division at early
time points after injury [1]. However, this expansion and
increase in proliferation were only present in sections rostral
and caudal of the injury and not within the epicenter of
the lesion. This discrepancy between studies could be due
to the varying severities of injury. Takahashi et al. compared
moderate and severe contusion injuries in rat and noted
that cell mitosis within the ependyma initially decreased in
response to injury; however, it later resumed at an increased
rate compared to control spinal cord [34]. A more severe
injury depressed proliferation for a longer period of time;
but once it resumed the rate was higher than in less severe
injuries. They also showed that Nestin and GFAP were
upregulated in response to injury regardless of whether
or not the ependymal cells expressed PCNA. In more
severe injuries the number of ependymal cells expressing
these markers increased despite a lack of other proliferative8 Stem Cells International
markers. Unlike in transection injuries, which feature a
localized mitotic response, cell division at the central canal
increasedsigniﬁcantlyinthecervicalandlumbarspinalcord.
Furthermore, the recovery of limb function correlated with
an increase in PCNA+ ependymal cells.
Later studies in a contusion injury of moderate severity
in mouse [36]a n dr a t[ 84] showed that the response to
contusive injury is conserved between mouse and rat. BrdU+
cellswereobservedinthewhitematterandtheoutercircum-
ference of the spinal cord within the injury epicenter and the
surrounding tissue, although the distribution of cell types
diﬀered among these areas. At the epicenter most BrdU+
cells coexpressed Ox42, a marker for microglia/macrophages
in rat, known as CD11b in the mouse. In regions rostral
and caudal to the injury site, the majority of mitotic cells
were Ng2+ OPCs,followedinnumberbyCC1+ oligodendro-
cytes, indicating some OPCs matured into oligodendrocytes.
Proliferation peaked three days after injury at the epicenter
of the injury [29, 30, 36, 84]. Interestingly, BrdU labeling
was asymmetric with regards to proximity to injury, with a
greater increase in the spinal segments rostral of the lesion
thanincaudalsegments.Thisasymmetricalproliferationwas
limited to proximal regions; in sections greater than four
mm rostral or caudal to the injury there were no asymmet-
rical diﬀerences in mitotic cell counts. This asymmetrical
response, and the fate of daughter cells in diﬀerent segments
of the spinal cord after injury, was corroborated by McTigue
et al. [33]. One week after injury, the greatest number of
mitoticcellswerelocatedinthemedialspinalcordanddorsal
horns. Since ependymal cells can migrate 70μm in three
days [29] and there is no described parenchymal stem cell
niche, one week was insuﬃcient to provide evidence for a
stem/progenitor cell niche in either the parenchyma or in the
ependymal layer.
Yoo and Wrathall enriched Ng2+ cells isolated from
injured rat spinal cord that were capable of self-renewal and
formed small spheres; however, they gave rise to oligoden-
drocytes but rarely astrocytes [83], and thus, they charac-
terized Ng2+ cells as fate restricted glial progenitors. Using a
CNP-EGFP transgenic mouse, in which all cells expressing 2-
3-cyclic nucleotide 3-phosphodiesterase (CNP) were labeled
with enhanced green ﬂuorescent protein (EGFP), Lytle et
al. diﬀerentiated between Ng2+ OPCs and Ng2+ non-OPCs
[17]. Both types of Ng2+ cells proliferated in response
to injury; however, they exhibited distinct spatiotemporal
population dynamics, with Ng2+ OPCs reaching a prolifer-
ative peak three days after injury and non-OPCs reaching a
peak seven days after injury. Although both Ng2+ cell types
upregulated Nestin in response to injury, non-OPCs did not
express CC1 at any time. Furthermore, Ng2+ OPCs followed
a developmental program of oligodendrogliosis. During the
acutephaseofinjury,Olig2wasupregulated,whileOlig1and
Nkx 2.2 were downregulated. At later time points, Olig1 and
Nkx2.2 were upregulated, while Olig2 expression decreased;
cells that underwent such changes in their transcriptional
proﬁle ultimately became CC1+ oligodendrocytes. These
ﬁndings contrast with an earlier report by Yamamoto et al.
where there was no expression of these transcription factors
in a rat model of transection [59]. It is more likely that the
diﬀerence between these two studies is due to injury type
rather than the choice of animal model.
In contrast to the stem/progenitor cell response to tran-
section injury, a contusion injury triggers a systemic mitotic
response through the entire rostrocaudal extent of the spinal
cord (Figure 1(b)). The cell fate of daughter cells also varies
between transection and contusion injury, with most daugh-
ter cells in the injury epicenter expressing markers of
inﬂammatory cells (i.e., microglia/macrophages); and most
cells in rostrocaudal regions acquiring OPC/oligodendrocyte
fate. In the contusion model, astrocytes are also produced
by stem/progenitor cells, but not neurons. However, the
proliferative response to injury is similar in that regardless of
transection or contusion injury, there is a proliferative peak
observed three days after injury.
5.3. Proliferation in Compression Models. Compression and
contusion injuries are similar in their pathology and have
comparable cellular responses to injury. Wu et al. found
that the Ng2+ cell response to compression injury resembled
contusion injury [38]. 24 hours after compression injury
there was a slight increase of Ng2+ cells in the subpial
white matter and dorsal funicles in regions ﬁve mm rostral
and caudal to the injury. One week after injury, there was
an increase of Ng2 immunoreactivity in the subpial white
matter along with a decrease in immunoreactivity in the
dorsal funicles. Many bipolar Ng2+ cells with long processes
extending from the subpial region of the dorsal spinal
cord colocalized with 3CB-2, a marker for RG cells. These
results support the hypothesis that there is a population of
stem/progenitor cells in the subpial white matter of the adult
spinal cord with features of RG cells [28, 52].
Proliferation at the central canal has also been observed
in compression models of SCI, similar to that in contu-
sive models. An analysis of ependymal proliferation and
expression of Nestin after clip compression injury reported
an increase in Ki-67+ cells 24 hours after injury [37].
The ependymal label index decreased after seven days and
returned to control levels by 14 days. This may be due to the
migration of the newly generated cells away from the central
canal, as reported by other groups in other injury models [3,
29]. Most of the Ki-67+ cells were located in the ependymal
layer adjacent to the lesion, with the number of labeled
cells decreasing with distance from the lesion [37]. Although
the labeling index increased, the number of ependymal cells
lining the central canal remained at control values for at
least seven days. An increase was ﬁrst observed at 14 days
when the ependyma appeared to have multiple layers of cells.
Interestingly, the severity of the injury did not aﬀect the
labeling index or distance from the injury epicenter at which
Ki67+ cells were present. Within six hours of injury there
was a little change in Nestin expression; however, 24 hours
after injury there was an increase in immunoreactivity. At
latertimepointsNestinexpressioncontinuedtoincreaseand
spread beyond the ependymal layer; however, not all Nestin+
cells were simultaneously Ki-67+, providing further evidence
that some stem/progenitor cells may upregulate neuronal
stem cell markers but not undergo mitosis in response to
injury. In minimal injury [29] and transection [59]S C IStem Cells International 9
models, some ependymal cells upregulated Nestin or other
neural stem cell markers, but did not express proliferative
markers. These cells may alternatively represent a population
of premitotic stem/progenitor cells that upregulate stem
cell markers prior to entering S-phase and mitosis, thus
explaining the lack of BrdU incorporation and negative
staining for other markers of active proliferation. Another
hypothesis is that some stem/progenitor cells may remain
dormantinthespinalcordandreexpressembryonic markers
in response to injury, but fail to follow a program of
neurogenesis due to an inhibitory environment [59]. Further
experiments in contusion models of SCI are necessary to
determine if the expression of stem cell markers without, or
priortomitosisisawidespreadfeatureofSCIorisdependent
on injury type and/or severity.
AlthoughthecompressionmodelofSCIisnotaspopular
asthecontusionandtransectionmodels,theysharecommon
features such as stem/progenitor cell proliferation peaking
at three days after injury. Furthermore, the pathological
features of the post injury spinal cord and cell fate of
daughter cells closely resemble endogenous responses to
contusive injury (Figure 1(c)).
6. TherapeuticStrategiesforSpinalCordInjury
One of the most promising tools for functional recovery
after SCI is the replacement of cells lost as a consequence
of trauma. Cell replacement can be achieved by the trans-
plantation of exogenous stem cells, such as cells derived
from embryonic stem cells (ESCs) [101, 102], Schwann cells
[103], and olfactory ensheathing cells [21, 39, 104–110].
Another promising treatment is the direct transplantation
of stem cell-derived neuronal subtypes into the spinal cord.
ESC-derived motor neurons engrafted and integrated into
the developing chicken spinal cord and into noninjured rat
spinal cord [111]. Transplantation of astrocytes improved
locomotor recovery in transected rats by promoting axonal
growth [43, 112], as did the transplantation of OPCs
by remyelinating axonal sheaths [113]. Although there is
evidence that these transplanted cells engraft and improve
motor function after SCI, the exact mechanisms of recovery
are not fully understood. The signiﬁcant functional recovery
observed in SCI animal models has led to human clinical tri-
als of stem cell therapies. Currently there are several stem cell
therapies in Phase I of clinical testing to treat various spinal
disorders, such as amyotrophic lateral sclerosis (ALS). These
include trials aimed at replacing lost and diseased motor
neuronsutilizingfetalneuroprogenitors[114],mesenchymal
stem cells (MSCs) [115], and olfactory ensheathing cells
[116]. Results published thus far indicate that the surgical
procedure and transplantation of nonallogeneic cells into
the human spinal cord are safe and well tolerated; however,
patients are being enrolled for further testing to verify safety
and determine eﬃcacy. Such therapies could also be applied
for the treatment of traumatic spinal injury. Recently, the
biotechnology company StemCells, Inc. announced at the
51st Annual Scientiﬁc Meeting of the International Spinal
Cord Society that they had transplanted human NSCs into
three patients with complete thoracic SCI. Despite having
no sensation below the injury level prior to surgery, two
of the three patients regained some degree of sensitivity to
touch,heat,andelectricalstimuli.StemCells,Inc.iscurrently
enrollingalargercohortofpatientstocontinuePhaseIsafety
testing and validate their initial ﬁndings.
Despite the encouraging results fromstemcell transplan-
tation, the use of certain stem cells can raise ethical concerns,
cells may be diﬃcult to obtain in suﬃcient quantities for the
treatment of human patients, and there are concerns about
tumorigenicity and immunogenicity. Thus, manipulating
endogenous stem/progenitor cells is an attractive alternative
regenerative therapy for SCI. Although an endogenous
mitotic program is activated in response to injury, there is a
persistenttissueshrinkageindicativeofamassivelossofcells.
The goal of manipulating endogenous stem/progenitor cells
is to increase proliferation to recuperate lost neurons, oligo-
dendrocytes, and astrocytes. Diﬀerentiating stem/progenitor
cells into neurons is a priority, as the endogenous response
appears to be biased toward replacing OPCs and astrocytes
rather than generating new neurons. A potential approach
for manipulating the endogenous response to injury is the
administration of growth factors or cytokines to modulate
the milieu in which endogenous cells are proliferating and
diﬀerentiating.
Brain-derived neurotrophic factor (BDNF), glial cell-
derived neurotrophic factor (GDNF), nerve growth factor
(NGF), ciliary neurotrophic factor (CTNF), vascular endo-
thelialgrowthfactor(VEGF),andmanyothergrowthfactors
have neuroprotective and neurotrophic properties that
ameliorate neuronal death after injury [15, 21, 22, 27, 117]
andhavepositiveeﬀectsonOPCproliferation,remyelination
of axonal sheaths [13], and axonal sprouting [15]. Other
factors may be useful for SCI treatment, including TNFα,
which is implicated in OPC proliferation [118], and BMP
family members which induce neurogenesis during develop-
ment and maintain the adult stem cell niche in the SVZ of
the cortex [119]. How best to deliver these factors to the
spinal cord is a current challenge. Possible means of delivery
include intraventricular injection, viral mediated gene thera-
py, nonviral delivery vehicles, intrathecal delivery to the site
of injury, and systemic administration. A few of these appro-
aches have already been tested in animal models of SCI and
other models of CNS injury.
Early reports on the isolation and culture of multipotent
spinal cord progenitors indicate that EGF and/or FGF2 is
necessary for neurosphere formation and the multipotential
diﬀerentiation capabilities of spinal stem/progenitor cells in
vitro [2, 58]. However, the number of FGF2+ cells increased
after contusive SCI, as did the expression of the gliogenic
factors CNTF and glial growth factor (GGF2) [35]. When
GGF2 and FGF2 were administered systemically, the number
of CC1+ oligodendrocytes and Ng2+ non-OPCs increased,
while the total number of Ng2+ OPCs was unaﬀected by
growth factor treatment [17]. The latter observation was
attributedtotheabilityofNg2+ OPCstomaintaintheirpop-
ulation number despite enhanced mitosis and diﬀerentiation
of their progeny. The failure of FGF2 to induce multipotency
in vivo suggests that regenerative therapies may need to be
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pathways. For example, Notch1 is upregulated during the
ﬁrst week after injury [59]. Notch1 inhibits neurogenesis; so
the inhibition of Notch1 may potentially increase the level of
neurogenesis in vivo. In vitro data reveals that neurospheres
originatingfrominjuredspinalcordandculturedinthepres-
ence of a Notch1 inhibitor generated more Tuj1+ cells than
neurospheres cultured without this inhibitor. A successful
combination therapy may need two or more components,
such as FGF2 to increase stem/progenitor cell proliferation
and Notch1 to encourage neuronal diﬀerentiation.
Other attempts to manipulate the in vivo environment
and induce changes in cell fate determination include the
direct injection of BMP4 into a hemisected spinal cord [18].
Sellers et al. noticed that cells generated seven days after
injury primarily gave rise to oligodendrocytes and correlated
with an increase in the levels of BMP4. To mimic the seventh
day post injury environment, they injected BMP4 into the
spinal cord 24 hours after injury. As a result, the total
number of GFAP+ cells and CC1+ cells decreased at the
injurysite.Reducingastrocytesmaybebeneﬁcialbyreducing
the occurrence of allodynia and/or reducing the amount
of neuroinhibitory molecules secreted by reactive astrocytes
[120]; however, reducing the number of oligodendrocytes
will negatively impact functional outcomes by reducing
the number of myelinating-capable oligodendrocytes. When
Noggin, a BMP4 antagonist, was injected at the same time
point to manipulate the post injury environment, GFAP+
cells increased and CC1+ cells decreased. Thus, there may be
conﬂicting cues in the spinal cord that aﬀect the ability of
stem/progenitor cells to generate speciﬁc cell types, and fac-
tors which are neurogenic during developmental processes
may not have the same eﬀect on adult stem/progenitor cells.
F u r t h e re v a l u a t i o no fg r o w t hf a c t o re ﬀects after SCI are
needed to develop optimal therapies to promote neurogene-
sis in vivo. Basic research to determine how and why spinal
stem/progenitor cells behave so diﬀerently in vitro and in
vivo may allow for the design of regenerative therapies that
increase cellular plasticity after injury. There is a wealth of in
vitro data that we can draw on to develop new combinatorial
therapies. For example, in vitro studies suggest that Olig2
and Mash1 enhance the diﬀerentiation of NSCs into mature
neurons [121]. Other studies have highlighted the role of
Pax6 on neuroprogenitor proliferation and diﬀerentiation in
culture. The overexpression of Pax6 in NSC cultures resulted
in an increased number of neurons [122]a n do nag r e a t e r
axonal growth [123]. Although Pax6 and Pax7 are transiently
expressed after injury [59], the timing and level of expression
may not be suﬃcient to induce neurogenesis. Further studies
on the eﬀects of these transcription factors in vivo should
be performed to determine if they are capable of improving
sensory and motor function after trauma.
Administration of growth factors, or lineage speciﬁc
transcription factors, by a viral vector is another method
for introducing therapeutic factors to the spinal cord.
AdenoviralmediatedoverexpressionofBDNFandNogginin
the adult striatum encouraged resident NPCs to diﬀerentiate
into functional neurons [124], a therapy which should be
tested in SCI. In a rat transection model, retroviral over-
expression of Ngn2 and Mash1, in combination with the
growth factors FGF2 and EGF, increased the number of
oligodendrocytes generated from proliferating NPCs and
also gave rise to new neurons [16]. Because of safety con-
cerns, nonviral delivery vehicles may be a preferable alter-
native. Nonviral delivery vehicles include polymers, lipids,
nanoparticles, and peptides [125]. For example, the peptide
Tet1,whichbindstotheneuronalgangliosideGT1b,wasable
to successfully transduce, with a high degree of speciﬁcity, a
large number of NSCs in the brain with a vector containing
luciferase and β-galactosidase [126].
Administration of growth factors can also be accom-
plished by transplanting stem cells that have undergone
genetic modiﬁcations to express growth factors in a speciﬁc
region of the spinal cord or CNS. MSCs expressing BDNF
preserved a retinal and optic nerve function when trans-
planted into a rat model of chronic ocular hypertension
[127], and improved motor function in SCI rats [128]. How-
ever, it was hypothesized that these functional improvements
were due to increased axonal sprouting and neuroprotective
mechanisms, rather than to a modulation of proliferation
and/or diﬀerentiation of endogenous cells. Nevertheless,
engineered MSCs that overexpress Noggin, NGF, IGF-I, Shh,
and/or other factors may increase the neurogenic capabilities
of the post injury spinal cord and/or promote the mitosis
of existing OPCs and NPCs. Bretzner et al. reported that
the transplantation of olfactory ensheathing cells resulted
in some functional recovery after compression SCI, as did
the intrathecal administration of BDNF [11]; however, when
both factors were administered together, motor function
was impaired. Similarly, Davies et al. found that culturing
astrocytes with BMP4 enhanced their engraftment and the
functional recovery of SCI rats [112], however astrocytes
cultured with CNTF prior to transplantation failed to
integrate and resulted in mechanical allodynia and thermal
hyperalgesia[129].Moreworkneedstobedonetodetermine
the optimal combination of factors and delivery vehicles to
replace spinal cord cells lost to trauma or disease.
A number of reports published in the last decade on
regenerative therapies for SCI highlight the discrepancy
betweentheinvitroandinvivostem/progenitorcellresponse
to growth factors and transcription factor overexpression,
as well as the complexity of treatment design. The response
to injury is complex; thus there is need for regenerative
treatmentstargetingmorethanonefactortonotonlychange
thepostinjuryenvironment,butalsotomodulateprogenitor
cell fate.
7. Conclusion
Some aspects of the mammalian response to SCI are com-
mon regardless of the injury type. However, other features,
suchasthelocation,extent,andrateofcellproliferation,vary
depending on the type and severity of the injury (Table 1,
Figure 1). In most injury models, proliferation begins within
24hoursofinjury.Generally,transectioninjurieshavehigher
rates of proliferation, particularly of the ependymal cells.
The majority of injuries, whether performed in rats or mice
and regardless of injury type, elicit a proliferative peak three
days after injury. The proliferative response declines withinStem Cells International 11
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one or two weeks and is close to control levels within three
to four months of injury. This time course appears to be
shorter in transection injuries. The rates of proliferation
correlate closely with the spontaneous recovery of some
motor function in mice and rats [30, 34, 36, 84], as well as
with improvements in motor function in lower vertebrates
[68, 69, 76]. Another common phenomenon after any type
of SCI is the migration of newly generated cells towards
the injury site. For example, in transection models, cells
migrated towards the transection gap [3, 29, 32] and in
contusion and compression models, cells migrated towards
the dorsal or lateral aspect of the spinal cord where the
injurious force had been applied [38, 130]. In transection
injuries the proliferative response is local, while in contusion
and compression injuries there is a response spanning
a greater extent of the rostrocaudal axis (Figure 1). This
broader response is likely due to contusion and compression
injuries aﬀecting a larger area of spinal tissue. Several studies
using a contusion model have reported more proliferative
cells rostral to the epicenter than caudal to it [33, 84]. This
asymmetry may be the consequence of disrupted axonal
conductance or an aberration in the serotonergic input in
regions caudal of the primary injury [131].
The cell types that proliferate after injury vary between
experimental injury models. However, this phenomenon
may be attributed to experimental factors, such as a limited
focus of each study, the selection of a transgenic approach, or
the choice of immunohistochemical markers (see Table 1).
Some studies only examined the ependymal cell response
to injury or that of a very speciﬁc cell population, such
as Ng2+ or Olig2+ cells. Nevertheless, taken together, the
literature suggests that ependymal cells of the adult spinal
cord are heterogeneous in the nature and that there are
distinct stem/progenitor cell populations located within
the parenchyma and ependymal layer that proliferate and
generate speciﬁc spinal cord cells after injury. In addition,
generated cells acquire diﬀerent fates depending on injury
type (Figure 1). After transection, the majority of prolif-
erative cells express astrocyte markers (GFAP+ or S100b+
cells) and contribute to the formation of a ﬁbrous glial
scar. However, in contusion and compression models the
majorityofnewcellsoutsideofthelesionexpressmarkersfor
OPCs (Ng2+) and later for mature oligodendrocytes (CC1+).
Compressive or contusive injuries result in ischemic and
necrotic conditions that contribute to the demyelination of
spinal tracts and cell death; so the replenishment of mature
myelinating cells is necessary to prevent further degradation
of axons [132]. Proliferation of OPCs is a mechanism
by which the spinal cord can restore signal transductance
through spared axons. Therefore, the replacement of the
oligodendrocyte population in response to treatment is an
important goal to achieve to develop successful regenerative
therapies. Although there is evidence of axonal sprouting
after injury [1] and potential increased neurogenesis after
some forms of injury [130], there is no evidence that lost
or damaged neurons in the mammalian spinal cord can
be replaced without a therapeutic intervention. Therefore,
increasing the number of neuronal lineage cells may be an
additional goal for the achievement of successful therapies.
Due to ethical issues, safety concerns, and technical
obstacles in the use of human stem cells for treatment,
the modulation of endogenous stem/progenitor cells in
the spinal cord represents an attractive alternative to
embryonic or induced pluripotent stem cell transplantation.
Since the proliferation of endogenous stem/progenitor cells
occurs during the ﬁrst three days after injury, therapeutic
approaches should target time points before the third day.
Therapeutic intervention should also be considered at later
time points to adjust the milieu in which the cells are dif-
ferentiating and maturing. Furthermore, as there are clearly
diﬀerences in the endogenous response between the diﬀerent
types of SCI, these therapies will need to be optimized for
injury type and severity. For example, inhibitors directed
against glial scar associated extracellular matrix components
will be more eﬀective in transection injuries, where a glial
scarisapathologicalfeaturewhichinhibitsaxonalsprouting.
Increasing the rate of neurogenesis should be a goal for
all injury types; however in contusive injuries it may be
beneﬁcial to supplement endogenous astrocyte generation,
as there is evidence that speciﬁc astrocyte subtypes may aid
in functional recovery after SCI [43, 129], although some
subtypes may result in impaired function and/or allodynia
[120,129].Disagreeingreports ontheeﬀectsofastrocyteson
functional improvement after SCI highlight the sensitivity of
the spinal cord to changes in cell populations and reﬂect a
need for careful studies on the contribution of glial-neuronal
interactions to regeneration. Laceration injuries to the spinal
cord may have a better functional outcome if oligodendroge-
nesis can be increased to promote the remyelination of axons
damaged by transection injury or other secondary injury
processes, as well as to myelinate newly generated neurons
by therapeutic intervention. In the era of personalized medi-
cine, understanding how endogenous stem/progenitor cells
proliferate and diﬀerentiate in response to diﬀerent forms
of SCI will enable the development of eﬀective regenerative
therapies.
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